Guidance
3 Evidence
3 Evidence
The appraisal committee (section 6) considered evidence submitted by Bristol-Myers Squibb and a review of this submission by the evidence review group. See the committee papers for full details of the evidence.
The appraisal committee (section 6) considered evidence submitted by Bristol-Myers Squibb and a review of this submission by the evidence review group. See the committee papers for full details of the evidence.